---
title: "MGUS (Monoclonal Gammopathy of Uncertain Significance) Service for Dorset"
ocid: "ocds-h6vhtk-07bb13"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07bb13"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-07bb13.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-07bb13.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS Dorset Integrated Care Board"
published: "2026-11-12"
---

# MGUS (Monoclonal Gammopathy of Uncertain Significance) Service for Dorset

Buyer: NHS Dorset Integrated Care Board  
Current stage: Award  
OCID: ocds-h6vhtk-07bb13

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07bb13)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-07bb13.json)

## Summary

NHS Dorset Integrated Care Board is commissioning a community-based monitoring service for people with monoclonal gammopathy of uncertain significance (MGUS), a blood condition requiring ongoing monitoring. The service is to operate across Dorset, follow the Dorset MGUS Monitoring Guidelines and work in an integrated way with primary care and haematology services. This is a health service rather than a supply of equipment or construction project. The contracted provider is expected to continue the established local monitoring model and its links between community, primary care and specialist services. The requirement concerns care delivery across Dorset and is intended to maintain continuity for the existing patient cohort.

The procurement has reached the award stage: NHS Dorset selected Mid Dorset Primary Healthcare Ltd to continue the service through a direct award under the Provider Selection Regime. The stated rationale is that the provider already operates the Dorset model, has delivered it successfully, and has established processes, workforce, patient knowledge and integration; the buyer found no alternative offering sufficient benefits to justify transition during this extension. The award is pending in the published data. The service period runs from 7 December 2026 to 25 June 2027, with a planned contract signature by 4 December 2026. The award value is £145,065 excluding VAT (£174,077 including VAT). One lot is recorded. The award was based on suitability and continuity, capability, quality, integration, value for money and avoiding operational and clinical transition risks.

For providers considering comparable future commissioning by NHS Dorset, this award indicates that credibility depends on more than the ability to provide monitoring in isolation. The selected provider’s advantage was an operational Dorset service with established delivery processes, an experienced workforce, knowledge of the patient cohort and working integration across primary care and specialist haematology. A competing service would need to demonstrate safe continuity for patients, effective clinical pathways, reliable governance and quality, and value for money, while showing how transition would improve outcomes or service benefits enough to warrant disruption. Relevant capability is community-based MGUS monitoring aligned with local clinical guidance and coordination between primary care and haematology. The short extension also reflects the buyer’s need to preserve service continuity while reviewing its future commissioning model across the cluster footprint.

## Notice

Provision of a community-based MGUS (Monoclonal Gammopathy of Uncertain Significance) monitoring service across Dorset, aligned with the Dorset MGUS Monitoring Guidelines and integrated with primary care and haematology services.

### Procurement Information

NHS Dorset considered the provider landscape and noted that, whilst other primary care providers may theoretically be capable of delivering elements of the service, Mid-Dorset PCN is the only provider currently operating the established Dorset MGUS monitoring model with existing processes, workforce, patient cohort knowledge and integration arrangements. No alternative provider was identified that would provide sufficient additional benefits to justify service transition for the duration of the proposed extension.NHS Dorset ICB is satisfied that Mid-Dorset PCN is the most suitable provider to continue delivery of the MGUS Monitoring Service. The provider has successfully delivered the service throughout the current MOU term, demonstrating quality, capability, integration with existing clinical pathways and value for money. The service is fully operational, integrated with primary care and specialist haematology services, and there have been no identified performance, quality or governance concerns that would indicate the need to seek an alternative provider. Having considered the provider landscape and available information, the ICB has not identified another provider capable of delivering materially improved outcomes, value or service benefits that would justify service transition during the proposed nine-month extension period. Awarding this short-term extension mitigates operational and clinical continuity risks whilst allowing sufficient time for commissioners to complete a wider strategic review of the future commissioning model across the cluster footprint. NHS Dorset therefore considers Mid-Dorset PCN to be the most suitable provider in accordance with the Provider Selection Regime key criteria and basic selection criteria.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/107765-2026 |
| Notice type | UK5 - Transparency Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 12 Nov 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | 7 Dec 2026 - 25 Jun 2027 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £145,065 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Pending |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS Dorset Integrated Care Board |
| Locality | DORCHESTER |
| Postcode area | Dorchester |
| Postcode | DT1 1XJ |
| Country | England |
| ITL 1 | TLK South West (England) |
| ITL 2 | TLK6 North Somerset, Somerset and Dorset |
| ITL 3 | TLK64 Dorset |
| Local authority | Dorset |
| Electoral ward | Dorchester West |
| Westminster constituency | West Dorset |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | MID DORSET PRIMARY HEALTHCARE LIMITED |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85000000 - Health and social work services

## Release History

- 12 Nov 2026 at 17:04 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/107765-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/107765-2026
  12th November 2026 - Transparency notice on Find a Tender

## Notice URLs

- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07bb13. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-07bb13.json.
